Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history shows termination for futility and posting of results, with Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow added under the Study Status/Document sections. A prior change to Completed and Results Submitted was removed from the history on 2025-10-22.SummaryDifference0.8%

- Check18 days agoChange DetectedA new history entry 'Revision: v3.6.3' was added, replacing the previous 'Revision: v3.6.2'. This reflects a platform/version update to the study record history display and does not modify the study content.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the study history page. The update does not change study content or navigation.SummaryDifference0.1%

- Check39 days agoChange DetectedThe record history now includes a line indicating recruitment is closed: 'No longer looking for participants', signaling the study is no longer enrolling participants. It also adds a new revision tag 'Revision: v3.6.0', marking an updated version of the study record and replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check47 days agoChange DetectedVersion v3.5.5 has been added to the study history, superseding the previous v3.5.4. This update records a new iteration of the study record without altering its substantive content.SummaryDifference0.1%

- Check61 days agoChange DetectedNew revision adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with Document Section and Study Status. The update also notes that a Quality Control Review Has Not Concluded and shows a Returned date of 2026-05-19.SummaryDifference0.7%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.